Modulation of the Expression of Lengthy Non-Coding RNAs H19, GAS5, and MIAT by Endurance Train within the Hearts of Rats with Myocardial Infarction
Lengthy non-coding RNAs (lncRNAs) have a crucial function within the regulation of cardiovascular perform. Dysregulation of lncRNAs is implicated within the development of cardiovascular illnesses together with myocardial infarction (MI). Concerning the useful results of train (Ex) on the advance of MI, this research aimed to research the consequences of post-MI Ex on the expression of MI-associated lncRNAs: H19, myocardial infarction affiliation transcript (MIAT), and progress arrest particular 5 (GAS5).
MI was induced by left anterior descending (LAD) coronary artery ligation in male Wistar rats. One week later, rats have been exercised underneath a moderate-intensity protocol for four weeks. Ultimately, hemodynamic parameters and cardiac perform indices have been measured. Evaluation of fibrotic areas and apoptosis was carried out by Masson’s trichrome staining and immunohistochemistry, respectively. Expression of genes was evaluated by real-time PCR.
Ex considerably diminished the fibrotic areas (P < 0.05) and apoptosis and elevated contractility indices (P < 0.01), and cardiac perform (P < 0.05) in MI teams. The diminished expression of H19 (P < 0.01) in MI rats returned to regular ranges by Ex. Ex considerably (P < 0.001) diminished the expression of MIAT and elevated the expression of GAS5 (P < 0.01), which had modified within the hearts of rats with MI.
The current research indicated the useful impact of Ex on the advance of cardiac perform and discount of fibrosis in infarcted coronary heart probably by regulation of the expression of lncRNAs: H19, GAS5, and MIAT.
Elevated Expression Degree of Lengthy Noncoding RNA H19 in Plasma of Sufferers with Myocardial Infarction
Lengthy noncoding RNAs (lncRNAs) are prolonged noncoding transcripts that are actively concerned in essential mobile pathways. Tissue-specific expression of lncRNAs in addition to its secretion into the physique fluids, has made lncRNAs in consideration as biomarkers of the illnesses. In accordance with the function of lncRNAs, particularly H19 in cardiac regeneration, it’s not shocking if their altered expression ranges result in cardiac illnesses.
Within the current research, the relative expression of H19 was in contrast within the plasma of atherosclerotic myocardial infarction and management people by actual time-PCR, and knowledge have been normalized utilizing GAPDH. The affiliation of plasma stage of lipid and homocystine with H19 expression was additionally thought of.
The potential of H19 to discriminate the case from management was studied utilizing the ROC evaluation. We discovered that the plasma stage of H19 transcript considerably elevated within the plasma of sufferers as compared with the management group. Moreover, the relative expression stage of H19 was straight related to the plasma homocystine stage.
The relative expression of H19 at threshold of 0.three confirmed 70% sensitivity and 94% specificity to discriminate instances from controls. This research revealed that the expression stage of H19 could also be thought of as a biomarker of myocardial infarction, though additional research are wanted to generalize this discovering.
BDNF (human) |
|||
B5341-.01 | ApexBio | 10 ug | EUR 711.6 |
BDNF, Human |
|||
HY-P7116A | MedChemExpress | 50ug | EUR 914.4 |
BDNF (human) |
|||
TP2069-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BDNF (human) |
BDNF (human) |
|||
TP2069-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BDNF (human) |
BDNF (human) |
|||
TP2069-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BDNF (human) |
BDNF (human) |
|||
TP2069-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BDNF (human) |
BDNF (human) |
|||
TP2069-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BDNF (human) |
BDNF (Human) |
|||
MBS5789515-INQUIRE | MyBiosource | INQUIRE | Ask for price |
BDNF, Human |
|||
MBS8575292-0005mg | MyBiosource | 0.005mg | EUR 245 |
BDNF, Human |
|||
MBS8575292-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Anti-Human BDNF Antibody |
|||
101-M138 | ReliaTech | 100 µg | EUR 399 |
Description: BDNF is a member of the NGF family of neurotrophic growth factors. Like other members of this family, BDNF supports neuron proliferation and survival. BDNF can bind to a low affinity cell surface receptor called LNGFR, which also binds other neurotrophins such as NGF, NT-3 and NT-4. However, BDNF mediates its neurotrophic properties by signaling through a high affinity cell surface receptor called gp145/trkB. BDNF is expressed as the C-terminal portion of a 247 amino acid polypeptide precursor, which also contains a signal sequence of 18 amino acid residue and a propeptide of 110 amino acid residues. Recombinant human BDNF is a 27.0 kDa homodimer of two 119 amino acid subunits linked by strong non-covalent interactions. Human and Mouse BDNF sequences are identical. |
Anti-Human BDNF Antibody |
|||
101-M139 | ReliaTech | 100 µg | EUR 399 |
Description: BDNF is a member of the NGF family of neurotrophic growth factors. Like other members of this family, BDNF supports neuron proliferation and survival. BDNF can bind to a low affinity cell surface receptor called LNGFR, which also binds other neurotrophins such as NGF, NT-3 and NT-4. However, BDNF mediates its neurotrophic properties by signaling through a high affinity cell surface receptor called gp145/trkB. BDNF is expressed as the C-terminal portion of a 247 amino acid polypeptide precursor, which also contains a signal sequence of 18 amino acid residue and a propeptide of 110 amino acid residues. Recombinant human BDNF is a 27.0 kDa homodimer of two 119 amino acid subunits linked by strong non-covalent interactions. Human and Mouse BDNF sequences are identical. |
Anti-Human BDNF Antibody |
|||
101-M229 | ReliaTech | 100 µg | EUR 399 |
Description: Brain-derived neurotrophic factor (BDNF) is a member of the NGF family of neurotrophic factors (also named neurotrophins) that are required for the differentiation and survival of specific neuronal subpopulations in both the central as well as the peripheral nervous system. The neurotrophin family comprises at least four proteins including NGF, BDNF, NT3, and NT4/ 5. These secreted cytokines are synthesized as prepropeptides that are proteolytically processed to generate the mature proteins. All neurotrophins have six conserved cysteine residues that are involved in the formation of three disulfide bonds and all share approximately 55% sequence identity at the amino acid level. Similarly to NGF, bioactive BDNF is predicted to be a noncovalently linked homodimer. BDNF cDNA encodes a 247 amino acid residue precursor protein with a signal peptide and a proprotein that are cleaved to yield the 119 amino acid residue mature BDNF. The amino acid sequence of mature BDNF is identical in all mammals examined. High levels of expression of BDNF have been detected in the hippocampus, cerebellum, fetal eye, and placenta. In addition, low levels of BDNF expression are also found in the pituitary gland, spinal cord, heart, lung, and skeletal muscle. BDNF binds with high affinity and specifically activates the TrkB tyrosine kinase receptor. |
Anti-Human BDNF Antibody |
|||
102-P02 | ReliaTech | 100 µg | EUR 245.7 |
Description: BDNF is a member of the NGF family of neurotrophic growth factors. Like other members of this family, BDNF supports neuron proliferation and survival. BDNF can bind to a low affinity cell surface receptor called LNGFR, which also binds other neurotrophins such as NGF, NT-3 and NT-4. However, BDNF mediates its neurotrophic properties by signaling through a high affinity cell surface receptor called gp145/trkB. BDNF is expressed as the C-terminal portion of a 247 amino acid polypeptide precursor, which also contains a signal sequence of 18 amino acid residue and a propeptide of 110 amino acid residues. Recombinant human BDNF is a 27.0 kDa homodimer of two 119 amino acid subunits linked by strong non-covalent interactions. Human and Mouse BDNF sequences are identical. |
Anti-Human BDNF Antibody |
|||
MBS1569902-01mg | MyBiosource | 0.1mg | EUR 375 |
Anti-Human BDNF Antibody |
|||
MBS1569902-5x01mg | MyBiosource | 5x0.1mg | EUR 1390 |
Antibody for Human BDNF |
|||
SPC-703D-A565 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 565. |
Antibody for Human BDNF |
|||
SPC-703D-A633 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 633. |
Antibody for Human BDNF |
|||
SPC-703D-A655 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 655. |
Antibody for Human BDNF |
|||
SPC-703D-A680 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 680. |
Antibody for Human BDNF |
|||
SPC-703D-A700 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 700. |
Antibody for Human BDNF |
|||
SPC-703D-APCCY7 | Stressmarq | 0.1mg | EUR 565.2 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to APC/Cy7. |
Antibody for Human BDNF |
|||
SPC-703D-DY350 | Stressmarq | 0.1mg | EUR 496.8 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Dylight 350. |
Antibody for Human BDNF |
|||
SPC-703D-DY405 | Stressmarq | 0.1mg | EUR 483.6 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Dylight 405. |
Antibody for Human BDNF |
|||
SPC-703D-DY488 | Stressmarq | 0.1mg | EUR 471.6 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Dylight 488. |
Antibody for Human BDNF |
|||
SPC-703D-DY594 | Stressmarq | 0.1mg | EUR 474 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Dylight 594. |
Antibody for Human BDNF |
|||
SPC-703D-DY633 | Stressmarq | 0.1mg | EUR 468 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Dylight 633. |
Antibody for Human BDNF |
|||
SPC-703D-P594 | Stressmarq | 0.1mg | EUR 488.4 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to PE/ATTO 594. |
Antibody for Human BDNF |
|||
SPC-703D-STR | Stressmarq | 0.1mg | EUR 477.6 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Streptavidin. |
Rabbit Anti Human BDNF Monoclonal Clone BEH-2 |
|||
IRBAHUBDNFBEH2C100UL | Innovative research | each | EUR 496 |
Description: Rabbit Anti Human BDNF Monoclonal Clone BEH-2 |
BDNF siRNA (Human) |
|||
MBS8230608-15nmol | MyBiosource | 15nmol | EUR 405 |
BDNF siRNA (Human) |
|||
MBS8230608-30nmol | MyBiosource | 30nmol | EUR 565 |
BDNF siRNA (Human) |
|||
MBS8230608-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
Recombinant Human BDNF |
|||
Z100065 | ABM | 10 µg | EUR 235 |
Description: BDNF is found in neurons of the central nervous system. It is expressed predominantly in hippocampus, cortex, and synapses of the basal forebrain. The biological activity of BDNF is mediated by a receptor that belongs to the trk family of receptors encoding a tyrosine-specific protein kinase. BDNF only binds weakly to the gp140trk receptor (to which NGF binds with high affinity), and it binds to the NGF receptor known as LNGFR. BDNF selectively supports the survival of primary sensory neurons and retinal ganglia. The factor supports survival and differentiation of certain cholinergic neurons and also some dopaminergic neurons in vitro. BDNF does not appear to act on sympathetic ganglia. In specific neurons of the central nervous system located in the hippocampus and the cortex the synthesis of BDNF is influenced by neuronal activity either positively (glutamate transmitter system) or negatively (GABA transmitter system). |
Recombinant Human BDNF |
|||
Z100069 | ABM | 1.0 mg | EUR 6900 |
Description: BDNF is found in neurons of the central nervous system. It is expressed predominantly in hippocampus, cortex, and synapses of the basal forebrain. The biological activity of BDNF is mediated by a receptor that belongs to the trk family of receptors encoding a tyrosine-specific protein kinase. BDNF only binds weakly to the gp140trk receptor (to which NGF binds with high affinity), and it binds to the NGF receptor known as LNGFR. BDNF selectively supports the survival of primary sensory neurons and retinal ganglia. The factor supports survival and differentiation of certain cholinergic neurons and also some dopaminergic neurons in vitro. BDNF does not appear to act on sympathetic ganglia. In specific neurons of the central nervous system located in the hippocampus and the cortex the synthesis of BDNF is influenced by neuronal activity either positively (glutamate transmitter system) or negatively (GABA transmitter system). |
RECOMBINANT HUMAN BDNF |
|||
GWB-DE906C | GenWay Biotech | 0.01 mg | Ask for price |
Recombinant Human BDNF |
|||
MBS7608556-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human BDNF |
|||
MBS7608556-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human BDNF |
|||
MBS7608556-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human BDNF |
|||
MBS7608556-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Human BDNF |
|||
MBS7609632-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human BDNF |
|||
MBS7609632-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human BDNF |
|||
MBS7609632-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human BDNF |
|||
MBS7609632-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
RECOMBINANT HUMAN BDNF |
|||
MBS232457-001mg | MyBiosource | 0.01mg | EUR 520 |
RECOMBINANT HUMAN BDNF |
|||
MBS232457-5x001mg | MyBiosource | 5x0.01mg | EUR 2160 |
Recombinant Human BDNF |
|||
MBS4159636-001mg | MyBiosource | 0.01mg | EUR 385 |
Recombinant Human BDNF |
|||
MBS4159636-1mg | MyBiosource | 1(mg) | EUR 7935 |
anti- BDNF antibody |
|||
FNab10014 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against BDNF |
anti- BDNF antibody |
|||
FNab00859 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against BDNF |
Rabbit anti-Homo sapiens (Human) BDNF Polyclonal Antibody |
|||
MBS7138282-INQUIRE | MyBiosource | INQUIRE | Ask for price |
BDNF, human recombinant |
|||
4004-10 | Biovision | each | EUR 333.6 |
BDNF, human recombinant |
|||
4004-1000 | Biovision | each | EUR 6571.2 |
BDNF, human recombinant |
|||
4004-250 | Biovision | each | EUR 2461.2 |
BDNF, human recombinant |
|||
4004-50 | Biovision | each | EUR 816 |
BDNF, human recombinant |
|||
P1007-.01 | ApexBio | 10 µg | EUR 261 |
Description: BDNF, expressed in E. coli, a potent neurotrophic factor. |
BDNF, human recombinant |
|||
P1007-.05 | ApexBio | 50 µg | EUR 658 |
Description: BDNF, expressed in E. coli, a potent neurotrophic factor. |
BDNF, human recombinant |
|||
P1007-.25 | ApexBio | 250 µg | EUR 2050 |
Description: BDNF, expressed in E. coli, a potent neurotrophic factor. |
BDNF, human recombinant |
|||
P1007-1 | ApexBio | 1 mg | EUR 5530 |
Description: BDNF, expressed in E. coli, a potent neurotrophic factor. |
BDNF, human recombinant |
|||
P1007-.1 | ApexBio | 100ug | EUR 900.8 |
Description: Neurotrophins|Brain-Derived Neurotrophic Factor |
Mouse Monoclonal anti-Human BDNF |
|||
hAP-0109 | Angio Proteomie | 100ug | EUR 250 |
Mouse Monoclonal anti-Human BDNF |
|||
hAP-0109A | Angio Proteomie | 100ug | EUR 250 |
Mouse Monoclonal anti-Human BDNF |
|||
hAP-0109B | Angio Proteomie | 100ug | EUR 250 |
InVivoMAb Anti-Human BDNF (Iv0093) |
|||
MBS1570123-01mg | MyBiosource | 0.1mg | EUR 405 |
InVivoMAb Anti-Human BDNF (Iv0093) |
|||
MBS1570123-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Human BDNF ELISA Kit |
|||
E16HE0041 | EnoGene | 96T | EUR 833.33 |
Human BDNF ELISA Kit |
|||
EHB0036 | Abclonal | 96Tests | EUR 625.2 |
Human BDNF ELISA Kit |
|||
E28L0224 | EnoGene | 96T | EUR 666.67 |
Human BDNF ELISA Kit |
|||
EK5126 | SAB | 96 tests | EUR 449 |
Human BDNF ELISA Kit |
|||
55R-1556 | Fitzgerald | 1 kit | EUR 615 |
Description: ELISA kit for detection of BDNF in the research laboratory |
Human BDNF ELISA Kit |
|||
ELA-E0011h | Nova Lifetech | 96tests | EUR 696 |
Human BDNF ELISA KIT |
|||
EF006120 | Nova Lifetech | 96tests | EUR 566 |
Human BDNF ELISA Kit |
|||
GWB-SKR197 | GenWay Biotech | 96 Tests | Ask for price |
Human BDNF ELISA Kit |
|||
GWB-ZZD022 | GenWay Biotech | 1x96 well plate | Ask for price |
Human BDNF ELISA kit |
|||
LF-EK50005 | Abfrontier | 1×96T | EUR 777.6 |
Human BDNF ELISA Kit |
|||
STJ150202 | St John's Laboratory | 1 kit | EUR 494.4 |
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of BDNF in human serum, plasma and other biological fluids |
Human BDNF ELISA Kit |
|||
MBS824804-5x96Tests | MyBiosource | 5x96Tests | EUR 2755 |
Human BDNF ELISA Kit |
|||
MBS824804-96Tests | MyBiosource | 96Tests | EUR 620 |
Human BDNF ELISA Kit |
|||
MBS9135790-5x96Tests | MyBiosource | 5x96Tests | EUR 2615 |
Human BDNF ELISA Kit |
|||
MBS9135790-96Tests | MyBiosource | 96Tests | EUR 570 |
Human, Rat, Mouse BDNF antibody |
|||
P0363 | Omnimabs | 100ul | EUR 150 |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D | Stressmarq | 0.1mg | EUR 331 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is unconjugated. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-A390 | Stressmarq | 0.1mg | EUR 385 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 390. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-A488 | Stressmarq | 0.1mg | EUR 384 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 488. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-A594 | Stressmarq | 0.1mg | EUR 384 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to ATTO 594. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-ALP | Stressmarq | 0.1mg | EUR 377 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Alkaline Phosphatase. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-APC | Stressmarq | 0.1mg | EUR 383 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to APC . |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-BI | Stressmarq | 0.1mg | EUR 380 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to Biotin. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-FITC | Stressmarq | 0.1mg | EUR 375 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to FITC. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-HRP | Stressmarq | 0.1mg | EUR 371 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to HRP. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-PCP | Stressmarq | 0.1mg | EUR 383 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to PerCP. |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703D-RPE | Stressmarq | 0.1mg | EUR 381 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is conjugated to RPE . |
Rabbit Anti-Human BDNF Polyclonal |
|||
SPC-703S | Stressmarq | 0.012mg | EUR 44 |
Description: A polyclonal antibody for BDNF from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human BDNF. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This BDNF antibody is unconjugated. |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807457-01mg | MyBiosource | 0.1mg | EUR 565 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807457-5x01mg | MyBiosource | 5x0.1mg | EUR 2000 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807483-01mg | MyBiosource | 0.1mg | EUR 520 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807483-5x01mg | MyBiosource | 5x0.1mg | EUR 1785 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807487-01mg | MyBiosource | 0.1mg | EUR 570 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807487-5x01mg | MyBiosource | 5x0.1mg | EUR 2025 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807503-01mg | MyBiosource | 0.1mg | EUR 570 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807503-5x01mg | MyBiosource | 5x0.1mg | EUR 2025 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807553-01mg | MyBiosource | 0.1mg | EUR 570 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807553-5x01mg | MyBiosource | 5x0.1mg | EUR 2020 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807570-01mg | MyBiosource | 0.1mg | EUR 555 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807570-5x01mg | MyBiosource | 5x0.1mg | EUR 1970 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807630-01mg | MyBiosource | 0.1mg | EUR 560 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807630-5x01mg | MyBiosource | 5x0.1mg | EUR 1990 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807632-01mg | MyBiosource | 0.1mg | EUR 565 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807632-5x01mg | MyBiosource | 5x0.1mg | EUR 2010 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807648-01mg | MyBiosource | 0.1mg | EUR 565 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807648-5x01mg | MyBiosource | 5x0.1mg | EUR 2005 |
Rabbit Anti-Human BDNF Polyclonal |
|||
MBS807679-01mg | MyBiosource | 0.1mg | EUR 570 |
Excessive-Throughput RNA Sequencing Evaluation of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Illness Development
The circulating microRNA (miRNA) profile has been broadly used for figuring out potential biomarkers towards viral infections. Nonetheless, knowledge on circulating microRNA expression patterns in dengue sufferers are scanty. Contemplating the impression of severity brought on by dengue an infection, circulating miRNA profiles in plasma of dengue sufferers could show to be helpful for growing early prognostic markers for the illness severity.
- Right here, we described an in-depth analytical research of small RNA sequencing knowledge obtained from the plasma of 39 dengue sufferers. Integrating bioinformatics and in vitro research, we recognized differentially expressed miRNAs (DEMs) (log2 fold change ≥1.5, P < 0.05) related to dengue illness development.
- In evaluating miRNA expression sample with the follow-up samples, 9 miRNAs have been discovered to exhibit an altered expression that might distinguish between extreme dengue and the convalescent sufferers.
- To grasp the abundance and specificity of the DEMs within the context of dengue an infection and illness development, eight top-hit DEMs have been additional validated within the dengue virus-infected cell traces in addition to within the affected person’s plasma and peripheral blood mononuclear cells (PBMCs) utilizing the quantitative reverse transcription-PCR (qRT-PCR) methodology.
- Importantly, receiver working curve evaluation additional confirmed that the plasma expression sample of hsa-miR-122-5p might differentiate between completely different phases of dengue an infection (space underneath the concentration-time curve [AUC] = 0.792), and dengue-negative sufferers with different febrile diseases (AUC = 0.984).
- The in silico evaluation of DEM goal genes instructed an enrichment of the pathways related to metabolism and irritation.
- Our research offers a world view of miRNA expression within the plasma from dengue sufferers and supplies a valuable useful resource of candidate miRNAs concerned in dengue an infection and illness development.
IMPORTANCE Dengue virus (DENV) an infection often causes dengue fever (DF) with flu-like sickness affecting infants, younger kids, and adults. The DF often evolves right into a probably deadly complication known as dengue extreme (DS) resulting in a fast fall in platelet rely together with plasma leakage, fluid accumulation, respiratory misery, and extreme bleeding.
The varied scientific spectrum of dengue illness, in addition to its important similarity to different febrile viral diseases, makes early identification tougher on this high-risk group. microRNAs (miRNAs) are small (∼19 to 21 nucleotides [nt] in size), noncoding RNAs, extraordinarily steady and simply detectable within the plasma; thus, they’ve potential as biomarkers for diagnosing and monitoring human illnesses.
This research supplies a complete evaluation of miRNAs circulating in plasma of dengue virus-infected sufferers and identifies the miRNA signatures which have biomarker potential for dengue an infection and illness development.
Anti-Human Kallikrein 15 Antibody |
|||
101-M529 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Recombinant Human Kallikrein-15, Sf9 |
|||
MBS147114-0001mg | MyBiosource | 0.001mg | EUR 240 |
Recombinant Human Kallikrein-15, Sf9 |
|||
MBS147114-0005mg | MyBiosource | 0.005mg | EUR 310 |
Recombinant Human Kallikrein-15, Sf9 |
|||
MBS147114-005mg | MyBiosource | 0.05mg | EUR 1360 |
Recombinant Human Kallikrein-15, Sf9 |
|||
MBS147114-5x005mg | MyBiosource | 5x0.05mg | EUR 5800 |
Recombinant Human Kallikrein-15 (KLK15) |
|||
MBS1371059-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1120 |
Recombinant Human Kallikrein-15 (KLK15) |
|||
MBS1371059-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 745 |
Recombinant Human Kallikrein-15 (KLK15) |
|||
MBS1371059-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 905 |
Recombinant Human Kallikrein-15 (KLK15) |
|||
MBS1371059-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 890 |
Recombinant Human Kallikrein-15 (KLK15) |
|||
MBS1371059-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1060 |
Mouse Monoclonal anti-human Kallikrein-15 |
|||
hAP-0429 | Angio Proteomie | 100ug | EUR 250 |
Kallikrein-15 Human Recombinant, sf9 |
|||
rAP-1237 | Angio Proteomie | Inquiry | Ask for price |
Human Kallikrein-15(KLK15) Elisa Kit |
|||
EK712825 | AFG Bioscience LLC | 96 Wells | EUR 0.3 |
Human Kallikrein-15 (KLK15) ELISA Kit |
|||
abx530231-96tests | Abbexa | 96 tests | EUR 687.5 |
Human Kallikrein- 15, KLK15 ELISA KIT |
|||
ELI-46403h | Nova Lifetech | 96tests | EUR 696 |
Human Kallikrein 15(KLK15)ELISA Kit |
|||
QY-E02951 | Qayee Biotechnology | 96T | EUR 433.2 |
Mouse Anti Human Kallikrein-3 |
|||
MBS140427-0005mg | MyBiosource | 0.005mg | EUR 240 |
Mouse Anti Human Kallikrein-3 |
|||
MBS140427-002mg | MyBiosource | 0.02mg | EUR 310 |
Mouse Anti Human Kallikrein-3 |
|||
MBS140427-01mg | MyBiosource | 0.1mg | EUR 610 |
Mouse Anti Human Kallikrein-3 |
|||
MBS140427-5x01mg | MyBiosource | 5x0.1mg | EUR 2405 |
Human Kallikrein-15 (KLK15) Antibody (Biotin Conjugate) |
|||
35623-05121 | AssayPro | 150 ug | EUR 315 |
Kallikrein 15 Antibody |
|||
abx037703-100ug | Abbexa | 100 ug | EUR 469.2 |
Kallikrein 15 Antibody |
|||
39370-100ul | SAB | 100ul | EUR 468 |
Kallikrein 15 Antibody |
|||
E300643 | EnoGene | 100ug/200ul | EUR 275 |
Description: Available in various conjugation types. |
Kallikrein 15 Antibody |
|||
abx037703-96tests | Abbexa | 96 tests | EUR 337.5 |
Kallikrein 15 Antibody |
|||
MBS9414353-01mL | MyBiosource | 0.1mL | EUR 420 |
Kallikrein 15 Antibody |
|||
MBS9414353-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
Kallikrein 15 Antibody |
|||
MBS851724-01mg | MyBiosource | 0.1mg | EUR 345 |
Kallikrein 15 Antibody |
|||
MBS851724-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Kallikrein 15 Antibody |
|||
MBS851724-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Kallikrein 15 Antibody |
|||
MBS851724-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Kallikrein 15 Antibody |
|||
MBS851724-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
KLK15 Kallikrein-15 Human Recombinant Protein |
|||
PROTQ9H2R5 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: KLK15 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 258 amino acids (22-256a.a) and having a molecular mass of 28.2kDa. ;KLK15 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
KLK2, Recombinant, Human (Kallikrein-2, Glandular Kallikrein-1, hGK-1, Tissue Kallikrein-2, Kallikrein 2) |
|||
MBS638290-001mg | MyBiosource | 0.01mg | EUR 890 |
KLK2, Recombinant, Human (Kallikrein-2, Glandular Kallikrein-1, hGK-1, Tissue Kallikrein-2, Kallikrein 2) |
|||
MBS638290-5x001mg | MyBiosource | 5x0.01mg | EUR 3790 |
Kallikrein-15 (Recombinant) |
|||
20-abx073427 | Abbexa |
|
|
KLK15 Human, Kallikrein-15 Human Recombinant Protein, sf9 |
|||
PROTQ9H2R5-1 | BosterBio | Regular: 5ug | EUR 380.4 |
Description: KLK15 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 249 amino acids (17-256a.a.) and having a molecular mass of 27.4kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa).;KLK15 is expressed with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human Kallikrein-15 (KLK15) AssayLite™ Antibody (RPE Conjugate) |
|||
35623-05151 | AssayPro | 150 ug | EUR 370 |
Human Kallikrein-15 (KLK15) AssayLite™ Antibody (APC Conjugate) |
|||
35623-05161 | AssayPro | 150 ug | EUR 370 |
Human Kallikrein-15 (KLK15) AssayLite™ Antibody (FITC Conjugate) |
|||
35623-05141 | AssayPro | 150 ug | EUR 370 |
Human Kallikrein Related Peptidase 15 (KLK15) Protein |
|||
abx073427-1g | Abbexa | 1 g | EUR 225 |
Human Kallikrein-15 (KLK15) AssayLite™ Antibody (PerCP Conjugate) |
|||
35623-05171 | AssayPro | 150 ug | EUR 410 |
Kallikrein 15 Rabbit pAb |
|||
E2820908 | EnoGene | 100ul | EUR 225 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Human Kallikrein Antibody |
|||
20353-05011 | AssayPro | 150 ug | EUR 175 |
Human Kallikrein-3 |
|||
MBS147355-02mg | MyBiosource | 0.2mg | EUR 560 |
Human Kallikrein-3 |
|||
MBS147355-05mg | MyBiosource | 0.5mg | EUR 960 |
Human Kallikrein-3 |
|||
MBS147355-1mg | MyBiosource | 1mg | EUR 1515 |
Human Kallikrein-3 |
|||
MBS147355-5x1mg | MyBiosource | 5x1mg | EUR 6485 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (AP) |
|||
MBS6452697-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (AP) |
|||
MBS6452697-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (PE) |
|||
MBS6452707-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (PE) |
|||
MBS6452707-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (APC) |
|||
MBS6452698-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (APC) |
|||
MBS6452698-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (HRP) |
|||
MBS6452701-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (HRP) |
|||
MBS6452701-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
Kallikrein-3 Human |
|||
rAP-1244 | Angio Proteomie | Inquiry | Ask for price |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (FITC) |
|||
MBS6452700-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (FITC) |
|||
MBS6452700-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
Kallikrein 15 (KLK15) (NM_138563) Human Over-expression Lysate |
|||
LS055554 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of kallikrein-related peptidase 15 (KLK15), transcript variant 2 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (Biotin) |
|||
MBS6452699-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (Biotin) |
|||
MBS6452699-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
Kallikrein 15 (KLK15) polyclonal antibody |
|||
ABP-PAB-10212 | Allele Biotech | 100 ug | Ask for price |
Human Kallikrein-10 (KLK10) |
|||
1-CSB-RP140394h | Cusabio |
|
|
Description: Recombinant Human Kallikrein-10(KLK10),partial expressed in E.coli |
Human Kallikrein-7 (KLK7) |
|||
1-CSB-YP012458HU | Cusabio |
|
|
Description: Recombinant Human Kallikrein-7(KLK7) expressed in Yeast |
Human Kallikrein-1 (KLK1) |
|||
1-CSB-EP012446HU | Cusabio |
|
|
Description: Recombinant Human Kallikrein-1(KLK1) expressed in E.coli |
Human Kallikrein-2 (KLK2) |
|||
1-CSB-EP012453HU | Cusabio |
|
|
Description: Recombinant Human Kallikrein-2(KLK2) expressed in E.coli |
Human Kallikrein-7 (KLK7) |
|||
1-CSB-EP012458HU | Cusabio |
|
|
Description: Recombinant Human Kallikrein-7(KLK7) expressed in E.coli |
Human Kallikrein-10 (KLK10) Antibody |
|||
30050-05111 | AssayPro | 150 ug | EUR 215 |
Human Kallikrein-11 (KLK11) Antibody |
|||
32102-05111 | AssayPro | 150 ug | EUR 215 |
Human Kallikrein-7 (KLK7) Antibody |
|||
32673-05111 | AssayPro | 150 ug | EUR 215 |
Human Kallikrein-3 (KLK3) Antibody |
|||
32743-05111 | AssayPro | 150 ug | EUR 215 |
Human Kallikrein-2 (KLK2) Antibody |
|||
32231-05111 | AssayPro | 150 ug | EUR 215 |
Human Kallikrein Purified |
|||
IHUKLK1MG | Innovative research | each | EUR 822 |
Description: Human Kallikrein Purified |
Kallikrein, Human Plasma |
|||
4093-50 | Biovision | each | EUR 326.4 |
Kallikrein, Human Plasma |
|||
KAL15-N-50 | Alpha Diagnostics | 50 ug | EUR 343.2 |
Kallikrein, Human Plasma |
|||
MBS135799-1mg | MyBiosource | 1mg | EUR 1085 |
Kallikrein, Human Plasma |
|||
MBS135799-5x1mg | MyBiosource | 5x1mg | EUR 4645 |
Kallikrein, Human Plasma |
|||
16-16-110112-50ug | Athens Research & Technology | 50ug | EUR 105 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 405) |
|||
MBS6452702-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 405) |
|||
MBS6452702-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 490) |
|||
MBS6452703-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 490) |
|||
MBS6452703-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 550) |
|||
MBS6452704-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 550) |
|||
MBS6452704-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 650) |
|||
MBS6452705-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 650) |
|||
MBS6452705-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 750) |
|||
MBS6452706-01mL | MyBiosource | 0.1mL | EUR 895 |
KLK15 (Kallikrein 15, KLK-15, KLK 15) (MaxLight 750) |
|||
MBS6452706-5x01mL | MyBiosource | 5x0.1mL | EUR 3875 |
Anti- Kallikrein Antibody |
|||
GWB-F4BF05 | GenWay Biotech | 1 ml | Ask for price |
Human KalliKrein 1 ELISA |
|||
E01A5491 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Kallikrein 11 (Kallikrein 11) Antibody |
|||
20-abx007794 | Abbexa |
|
|
Kallikrein 11 (Kallikrein 11) Antibody |
|||
20-abx008292 | Abbexa |
|
|
Kallikrein 11 (Kallikrein 11) Antibody |
|||
abx234457-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti-Human Kallikrein 13 Antibody |
|||
101-M528 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Anti-Human Kallikrein 3 Antibody |
|||
101-M530 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Anti-Human Kallikrein 4 Antibody |
|||
101-M531 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Anti-Human Kallikrein 5 Antibody |
|||
101-M532 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Anti-Human Kallikrein 7 Antibody |
|||
101-M533 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Anti-Human Kallikrein 8 Antibody |
|||
101-M534 | ReliaTech | 100 µg | EUR 399 |
Description: The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer. |
Recombinant Human Kallikrein-11 |
|||
7-03037 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Kallikrein-11 |
|||
7-03038 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Kallikrein-11 |
|||
7-03039 | CHI Scientific | 100µg | Ask for price |
Recombinant Human Kallikrein-11 |
|||
MBS140562-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human Kallikrein-11 |
|||
MBS140562-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human Kallikrein-11 |
|||
MBS140562-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human Kallikrein-11 |
|||
MBS140562-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
Recombinant Human Kallikrein-10 |
|||
MBS9421984-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human Kallikrein-10 |
|||
MBS9421984-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human Kallikrein-10 |
|||
MBS9421984-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human Kallikrein-10 |
|||
MBS9421984-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
Recombinant Human Kallikrein-10 |
|||
MBS146508-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human Kallikrein-10 |
|||
MBS146508-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human Kallikrein-10 |
|||
MBS146508-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human Kallikrein-10 |
|||
MBS146508-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
Recombinant Human Kallikrein-13 |
|||
MBS140730-0001mg | MyBiosource | 0.001mg | EUR 240 |
Recombinant Human Kallikrein-13 |
|||
MBS140730-0005mg | MyBiosource | 0.005mg | EUR 310 |
Recombinant Human Kallikrein-13 |
|||
MBS140730-005mg | MyBiosource | 0.05mg | EUR 1360 |
Recombinant Human Kallikrein-13 |
|||
MBS140730-5x005mg | MyBiosource | 5x0.05mg | EUR 5800 |
Human Kallikrein-11 ELISA Kit |
|||
MBS9425945-5x96Tests | MyBiosource | 5x96Tests | EUR 2820 |
Human Kallikrein-11 ELISA Kit |
|||
MBS9425945-96Tests | MyBiosource | 96Tests | EUR 615 |
Human Kallikrein-10 ELISA Kit |
|||
MBS9425984-5x96Tests | MyBiosource | 5x96Tests | EUR 2820 |
Human Kallikrein-10 ELISA Kit |
|||
MBS9425984-96Tests | MyBiosource | 96Tests | EUR 615 |
Human Kallikrein-10 ELISA Kit |
|||
MBS765413-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3900 |
Human Kallikrein-10 ELISA Kit |
|||
MBS765413-48StripWells | MyBiosource | 48-Strip-Wells | EUR 340 |
Human Kallikrein-10 ELISA Kit |
|||
MBS765413-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2045 |
Human Kallikrein-10 ELISA Kit |
|||
MBS765413-96StripWells | MyBiosource | 96-Strip-Wells | EUR 455 |
Human Kallikrein-10 ELISA Kit |
|||
MBS2881922-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 4080 |
Human Kallikrein-10 ELISA Kit |
|||
MBS2881922-48StripWells | MyBiosource | 48-Strip-Wells | EUR 390 |
Human Kallikrein-10 ELISA Kit |
|||
MBS2881922-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2220 |
Human Kallikrein-10 ELISA Kit |
|||
MBS2881922-96StripWells | MyBiosource | 96-Strip-Wells | EUR 520 |
Human Kallikrein-11 ELISA Kit |
|||
MBS2881113-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 4080 |
Human Kallikrein-11 ELISA Kit |
|||
MBS2881113-48StripWells | MyBiosource | 48-Strip-Wells | EUR 390 |
Human Kallikrein-11 ELISA Kit |
|||
MBS2881113-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2220 |
Human Kallikrein-11 ELISA Kit |
|||
MBS2881113-96StripWells | MyBiosource | 96-Strip-Wells | EUR 520 |
Human Kallikrein ELISA Kit |
|||
MBS3803068-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human Kallikrein ELISA Kit |
|||
MBS3803068-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human Kallikrein ELISA Kit |
|||
MBS3803068-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human Kallikrein ELISA Kit |
|||
MBS3803068-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Recombinant Human Kallikrein-1 |
|||
7-03028 | CHI Scientific | 20µg | Ask for price |
Recombinant Human Kallikrein-1 |
|||
7-03029 | CHI Scientific | 100µg | Ask for price |
Recombinant Human Kallikrein-1 |
|||
7-03030 | CHI Scientific | 1mg | Ask for price |